BioSignia Announces Agreement To Deliver Chronic Disease Prediction Technology Through Pharmacy Chain Kerr Drug


Share on LinkedIn

Research Triangle Park NC – May 9, 2007 – BioSignia, a leading preventative healthcare technology company, today announced the signing of a licensing agreement with regional pharmacy chain Kerr Drug. BioSignia’s health risk assessment (HRA) engine significantly improves prevention and management of chronic diseases by focusing on individualized disease risk assessment (DRA).

Under terms of the agreement, BioSignia’s revolutionary Know Your Number® testing tool will be available to customers at participating Kerr Health Care Centers in North Carolina. Know Your Number is currently not available through any other pharmacy chain nationwide.

Know Your Number predicts the onset of preventable diseases, compares your current health status against your peers, reveals what chronic disease risks are modifiable and lets you know what factors (e.g. lack of exercise, smoking) are contributing to the risks of developing specific chronic conditions. Findings are communicated in easy-to-interpret, visually compelling reports that also help individuals track their progress.

Kerr Drug is deeply committed to providing the highest quality health and wellness services to patients, the medical community and healthcare sponsors. Adding Know Your Number to the roster of solutions already offered at its health care centers serves to further the company’s mission of being the premier community pharmacy in North Carolina.
“Know Your Number is, by no means, a standard health risk assessment tool,” commented Joe Heidrick, R.Ph., PharmD and program coordinator at Kerr Drug. “It evaluates and reports a person’s chances of developing a chronic disease in a much more accurate, actionable manner.”

Driven by a powerful, patented predictive technology, Know Your Number is the first and only clinically based multi-dimensional tool to predict an individual’s risk of onset, progression, or life expectancy related to multiple chronic diseases.
“We are extremely excited at the opportunity to work with one of the most recognized and respected retail organizations in the nation,” commented Tim Smith, CEO of BioSignia. “We firmly believe in the power of the Know Your Number solution and the benefits it will deliver to Kerr Drugs’ customers.”

About BioSignia
Headquartered in Research Triangle Park, NC, BioSignia is a leading technology company focused on bringing innovative predictive modeling solutions to the preventive health and life insurance markets. At the core of BioSignia’s flagship solution, Know Your Number, is the company’s proprietary synthesis modeling approach to chronic disease risk prediction. In 2004, BioSignia received the Disease Management Association of America’s prestigious award for Best Enabling Tool for Disease Management. Since then, the company’s talented R&D team has continued to advance synthesis modeling, continuously updating it to reflect the ever expanding need for effective chronic disease prevention, management and treatment. For more information, visit

About Kerr Drug
Kerr Drug is one of the most recognized and respected names in the chain drug industry. With its roots in the Carolinas and headquarters in Raleigh, North Carolina, Kerr Drug is taking the vision of community pharmacy farther than any other drug chain. The company has placed its future on its unique ability to provide patients, the medical community, and health plan sponsors, access to the most comprehensive and convenient health and wellness offering in the industry. With a mission to be the most comprehensive provider of pharmacy and related health care services, while continuing to be the most reliable provider of health related and convenience items, Kerr is currently providing services that far exceed the traditional drug store mix. For more information, please visit

News Editor
CustomerThink offers a free news posting service for press releases relevant to our community. To submit your press release to our news editor, send an email to [email protected] with the press release headline and main content in the email subject line and body, respectively. That's it! Approved press releases will appear in our news category within one business day of submission.


Please use comments to add value to the discussion. Maximum one link to an educational blog post or article. We will NOT PUBLISH brief comments like "good post," comments that mainly promote links, or comments with links to companies, products, or services.

Please enter your comment!
Please enter your name here